LIVE TODAYSRHvsRCBDream11 Tips โ†’
Skip to content
CricJosh
International Cricket

Anti-Doping Hearing Sri Lanka Spinner May 2026: ICC Decision Decoded

Rishi Bhatnagar 19 May 2026 Updated 19 May 2026 ~4 min read ~763 words
ICC anti-doping documents on a desk representing the hearing outcome

Share this article

Anti-doping cases in cricket land relatively rarely, and when they do, the procedural reasoning is more important than the headline. The May 2026 resolution of the Sri Lanka spinner's case is the kind of decision that sets a quiet precedent. The ICC's reasoned decision has been published with the player named in the document; reporting conventions allow the name once the decision is public. The case turns on a specified substance, a 6-month suspension and a careful note on intent.

The substance and the test window

The substance identified in the player's sample is a beta-2 agonist used in over-the-counter asthma medication, which is on the WADA prohibited list except where a Therapeutic Use Exemption has been granted. The test window was an out-of-competition sample collected in February 2026. The player had not filed a TUE for the substance at the time of the sample. The substance is classified by WADA as a Specified Substance, which permits a shorter sanction window where intent is not established.

The hearing process

The case followed the standard ICC anti-doping process: notification, B-sample test, charge filing, and an independent disciplinary tribunal hearing held under the chair of an ICC-appointed legal panel. The player's defence acknowledged the positive sample but argued no intent to enhance performance. Medical documentation was provided showing a prescribing physician had recommended an over-the-counter equivalent containing the substance. The argument was reduced fault rather than no-fault.

The decision: 6-month suspension

The tribunal imposed a 6-month suspension, backdated to the date of provisional suspension. The reasoning rejected the no-fault defence because the player had a personal responsibility to verify the substance against the WADA prohibited list. The reasoning accepted reduced fault because the medication was prescribed and the player had a documented asthma history pre-dating the test. The Specified Substance classification was the structural permission for the shorter sanction window.

What it means in cricket calendar terms

The 6-month term, backdated to provisional suspension in February 2026, makes the player eligible to return in August 2026. The next major Sri Lanka assignment after that point is the home Test series against Bangladesh in September. The player returns to the selection pool but will need domestic match readiness โ€” Sri Lanka A is the realistic re-entry route.

Precedent context

The closest cricket precedent is the 2020 case involving a Pakistan U19 player, which resulted in a 12-month sanction for a similar substance category but where the personal-responsibility threshold was deemed not met. The 2026 decision sits closer to the 2018 New Zealand case involving an off-spinner where a 6-month sanction was imposed with similar mitigating documentation. The case is also an indication that the ICC's anti-doping tribunal continues to draw distinctions in fault assessment.

SLC's response

Sri Lanka Cricket's public response was procedural: it accepted the decision, noted that the player would re-enter selection contention from August, and emphasised the board's commitment to anti-doping education. The internal response is reportedly more substantive โ€” the medical team has been instructed to file TUEs proactively for any centrally contracted player with a documented condition that involves prohibited-list substances.

The wider point on cricket anti-doping

Cricket has historically been undertested compared to track and field or cycling, but the volume of out-of-competition testing has increased since 2022. Specified Substance positives โ€” typically asthma medication, weight-management drugs and cold medication โ€” make up the majority of cricket anti-doping cases. The structural answer is education and proactive TUE filing, not punitive sanctions for inadvertent positives. The May 2026 decision is consistent with that direction.

What to watch

The player's August return will be quiet rather than dramatic. The SLC medical and anti-doping protocols, particularly TUE filing volume in the next 12 months, will be the more substantive consequence of the case.

Share this article

RB

Rishi Bhatnagar

Expert in: International

Cricket analyst and content writer at CricJosh, covering International with 48 articles published.